Listed by the USPTO as PRIEST, JESSICA MARIE
Tech Center 1600 • Art Units: 1618 1642 1643 1644
This examiner grants 0% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18404727 | ANTI-FIBROTIC TISSUE RESIDENT MEMORY T CELLS AND USES THEREOF | Non-Final OA | THE JOHNS HOPKINS UNIVERSITY |
| 18472160 | METHODS OF TREATING OBESITY, DIABETES, AND LIVER DYSFUNCTION | Non-Final OA | REGENERON PHARMACEUTICALS, INC. |
| 18571614 | Treatment of Cardiovascular Disease with TREM-1 Antigen Binding Proteins | Non-Final OA | AMGEN INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your StrategyJessica Marie Priest examines applications in Art Unit 1618 in Tech Center 1600 (Biotechnology & Pharmaceuticals).